PHA treatment also reduced CD68+/SYP+ on both sides of the hippocampi (p<0.001, Fig. 9a & b) and GFAP+/SYP+ cells in the hippocampi ipsilateral to stroke injury (p<0.001, Fig. 9c & d). This evidence concerns the gene GFAP and stroke disorder.